Created with Highcharts 11.1.0Apr '24Jul '24Oct '24Jan '251.001.15

Profile

Edit
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.
URL https://www.achillestx.com
Investor Relations URL N/A
HQ State/Province N/A
Sector Health Care
Industry Biotechnology
Next Earnings Release Apr. 04, 2025 (est.)
Last Earnings Release Nov. 14, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Edit
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.
URL https://www.achillestx.com
Investor Relations URL N/A
HQ State/Province N/A
Sector Health Care
Industry Biotechnology
Next Earnings Release Apr. 04, 2025 (est.)
Last Earnings Release Nov. 14, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A
Quickflows